Chugai Pharmaceutical Co. Ltd.
CHGCF | OTC
$42.25
+$1.51 (+3.71%)
At close: Oct 30, 2026, 3:40 PM ET
$42.25
$0.00 (+0.01%)
After-hours:
Oct 30, 2026, 4:00 PM ET
+3.71%
(1D)No price chart data available for 1D timeframe.
Rating
73.8
+17.1 ptsFundamentals Excellent
Market Sentiment Neutral
Moat Wide
Sector Rank #39/1028 (Top 4%)
Key Statistics
Market Data
Market Cap $69.54B
1D Range
42.25 44.61
52W Range
35.27 68.07
Valuation (TTM)
PE 21.71
PB 5.24
EV/EBITDA 14.30
Valuation (NTM)
Forward PE 18.19
Forward PEG 1.30
Price Target $0.00
Cash Flow
FCF Yield 3.3%
SBC Adj. FCF Yield 3.3%
SBC Impact N/A
Margins
Gross Margin 71.5%
Operating Margin 46.5%
FCF Margin 25.7%
Growth (CAGR)
Revenue 3Y | 5Y 3.5% |
9.8%
Dil EPS 3Y | 5Y 14.4% |
14.4%
FCF 3Y | 5Y 24.0% |
15.0%
Returns
ROA 21.2%
ROE 25.0%
ROIC 22.2%
Financial Health
Net Cash
¥869B ($5.52B)
Current Ratio 6.39
Interest Coverage 720.02
Dividends
Div Yield 3.17%
Payout Ratio 0.4%
FCF Payout Ratio 96.5%
Loading financial charts...
Profile
Chugai Pharmaceutical Co., Ltd. engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals. Its operations are carried out through the Domestic and Over...
Sector Healthcare
Industry Drug Manufacturers - General
Employees 7,872
IPO Date Aug 3, 2012
Website www.chugai-pharm.co.jp
Fiscal Year n/a
Latest News
No news articles available yet.
Earnings
Latest Earnings
Oct 27, 2026
EPS
$0.59
Beat +21.38%
YoY:
+14.53% REV
$2.57B
Beat +17.11%
YoY:
+14.17%Next Earnings
Feb 4, 2027
EPS Est
Pro
Rev Est
Pro
Add to Watchlist
Select watchlists to add or remove CHGCF